A Randomized Multicenter Study for Isolated Skin Vasculitis (NCT02939573)

🧪 Interventions in This Study

• Colchicine (DRUG)
• Dapsone (DRUG)
• Azathioprine (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (16 Sites)

• University of Kansas Medical Center — Kansas City, Kansas
• Boston University School of Medicine — Boston, Massachusetts
• Mayo Clinic — Rochester, Minnesota
• Northwell Health — Lake Success, New York
• Hospital for Special Surgery — New York, New York
• Cleveland Clinic — Cleveland, Ohio
• Penn State Hershey Medical Center — Hershey, Pennsylvania
• University of Pennsylvania — Philadelphia, Pennsylvania
• Vanderbilt University — Nashville, Tennessee
• UT Southwestern Medical Center — Dallas, Texas
• University of Utah — Salt Lake City, Utah
• University of Virginia — Charlottesville, Virginia
• St. Joseph's Healthcare — Hamilton, Ontario
• University of Toronto Mount Sinai Hospital — Toronto, Ontario
• McGill University Health Centre — Montreal, Quebec
• Tohoku Medical and Pharmaceutical University Hospital — Kyoto,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Primary Cutaneous Vasculitis clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.